期刊文献+

肝癌中烯酯酰辅酶A水解酶1的表达及其亚细胞定位 被引量:1

Expression levels of Ech1 in hepatocarcinoma and subcellular location
下载PDF
导出
摘要 目的探讨烯酯酰辅酶A水解酶1(enoyl coenzyme A hydratase 1,Ech1)表达变化在肝癌中的意义及Ech1的亚细胞定位与肿瘤恶性生物学行为的关系。方法应用免疫组化法检测20例正常肝组织和30例原发性肝癌组织中Ech1的表达;应用亚细胞分离法检测Ech1在Hca-F和FEch1下调细胞的四种不同亚细胞组分中的表达。结果 Ech1在原发性肝癌中的表达高于正常肝组织,差异有统计学意义(P<0.05);Ech1表达与患者年龄、AFP值及是否伴有肝硬化或伴有病毒性肝炎差异无统计学意义(P>0.05)。Ech1在Hca-F和FEch1下调细胞的四种亚细胞组分中表达均定位于细胞质和细胞膜,并且细胞质表达强于细胞膜,细胞核和细胞骨架部分中不表达。结论 Ech1在肝癌组织中的表达明显高于正常肝组织,提示其可能与肝癌的发生、发展有关;体外培养细胞中Ech1表达调控对其亚细胞定位的改变没有影响,Ech1对肿瘤恶性生物学行为的影响可能不是通过其亚细胞定位改变而实现的。 Purpose To study the expression of Eehl in hepatoearcinoma and its clinical significance, and to explore the relationship between subcellular location of Echl and malignant biologic behaviour of hepatocareinoma. Methods hnmunohistochemieal analysis was used to detect Echl expression in the 20 cases of normal liver tissue and the 30 cases of hepatocarcinoma. Subcellular location of Ecbl in Hea-F and FE,.hl -down cell was observed with subcellular protein extraction. Results The expression of Echl in primary hepa- tocarcinoma was increased compared to that of normal liver tissues ( P 〈 0. 05 ) , while there was no significant difference between the expression of Echl with the age, AFP, and with or without liver cirrhosis or hepatitis virus in hepatocarcinoma (P 〉 0. 05). Echl was found expressed almost at the same location although the expression level one is normal and the other is downregulation. Echl expres- sion was found in cytosol, membrane fraction, and its expression was higher in eytosol than other fractions both in Hca-F cell and Eehl downregulated Hca-F cell. Conclusions The expression of Echl in primary hepatocarcinoma was increased, which may indicate that Echl is a critical factor in the development of primary hepatocareinoma, but the subcellular location of Echl has not much contribution to that.
出处 《临床与实验病理学杂志》 CAS CSCD 北大核心 2015年第3期247-250,共4页 Chinese Journal of Clinical and Experimental Pathology
基金 国家自然科学基金(81071725) 辽宁省教育厅科研(L2012329) 辽宁省财政厅基金(20121203)
关键词 肝肿瘤 Ech1 亚细胞定位 hepatic neoplasm Echl Sub-cellular location
  • 相关文献

参考文献24

  • 1Agnihotri G, Liu H W. Enoyl-CoA hydratase: reaction, mechanism, and inhibition[J]. Bioorg Med Chem, 2003,11(1):9-20.
  • 2Takadate T, Onogawa T, Fukuda T, et al. Novel prognostic protein markers of resectable pancreatic cancer identified by coupled shotgun and targeted proteomics using formalin-fixed paraffin-embedded tissues[J]. Int J Cancer, 2013,132(6):1368-82.
  • 3Yokoyama Y, Tsuchida S, Hatayama I, et al. Loss of peroxisomal enzyme expression in preneoplastic and neoplastic lesions induced by peroxisome proliferators in rat livers[J]. Carcinogenesis, 1992,13(2):265-9.
  • 4Yokoyama Y, Kuramitsu Y, Takashima M, et al. Proteomic profiling of proteins decreased in hepatocellular carcinoma from patients infected with hepatitis C virus[J]. Proteomics, 2004,4(7):2111-6.
  • 5Kim H K, Park W S, Kang S H, et al. Mitochondrial alterations in human gastric carcinoma cell line[J]. Am J Physiol Cell Physiol, 2007,293(2):761-71.
  • 6Nishigaki R, Osaki M, Hiratsuka M, et al. Proteomic identification of differentially-expressed genes in human gastric carcinomas[J]. Proteomics, 2005,5(12):3205-13.
  • 7Yeh C S, Wang J Y, Cheng T L, et al.Fatty acid metabolism pathway play an important role in carcinogenesis of human colorectal cancers by Microarray-Bioinformatics analysis[J]. Cancer Lett, 2006,233(2):297-308.
  • 8Jiang Z, Wu C L, Woda B A, et al. Alpha-methylacyl-CoA racemase: a multi-institutional study of a new prostate cancer marker[J]. Histopathology, 2004,45(3):218-25.
  • 9Kageyama T, Nagashio R, Ryuge S, et al. HADHA is a potential predictor of response to platinum-based chemotherapy for lung cancer[J]. Asian Pac J Cancer Prev, 2011,12(12):3457-63.
  • 10Sheng K H, Yao Y C, Chuang S S, et al. Search for the tumor-related proteins of transition cell carcinoma in Taiwan by proteomic analysis[J]. Proteomics, 2006,6(3):1058-65.

二级参考文献25

共引文献3

同被引文献14

  • 1Peng S, Yang QX, Zhang T, et al. Lobaplatin-TACE combined with radioactive 125I seed implantation for treatment of primary bepatocellular carcinomaFJ]. Asian Pac J Cancer Prev, 2014, 15 (13) :5155-5160.
  • 2Deipolyi AR, Iafrate AJ, Zhu AX, et al. High lung shunt frac- tion in culorectal liver tumors is associated with distant metasta- sis and decreased survival [J]. J Vasc Interv Radiol, 2014, 25 (10) : 1604-1608.
  • 3Smits ML, Nijsen JF, van den Bosch MA, et al. Holmium-166 radioembolisation in patients with unresectable, chemorefracto- ry liver metastases (HEPAR trial): a phase 1, dose-escalation study [J]. Lancet Oncol, 2012, 13(10):1025-1034.
  • 4Giammarile F, Bodei L, Chiesa C, et al. EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterialradioactive compounds [J~. Eur J Nucl Med Mol Imaging, 2011, 38(7) :1393-1406.
  • 5Yamamuto Y, Chikawa J, Uegaki Y, et al. Histological type of Thorotrast-induced liver tumors associated with the transloca- tion of deposited radionuclides [J3. Cancer Sci, 2010, 101 (2) 336-340.
  • 6Tsurusaki M, Okada M, Kuroda H, et al. Clinical application of 18F-fluorodeoxyglucose positron emission tomography for as- sessment and evaluation after therapy for malignant hepatictumor [J]. J Gastroenterol, 2014, 49(1)~46-56.
  • 7Wen JC, Sai V, Straatsma BR, et al. Radiation-related cancer risk associated with surveillance imaging for metastasis from choroidal melanoma [J]. JAMA Ophthalmol, 2013, 131(1)~ 56-61.
  • 8Biising KA, Sch~ nberg SO, Brade J, et al. Impact of blood glucose, diabetes, insulin, and obesity on standardized uptake values in tumors and healthy organs on 18F-FDG PET/CT [J]. Nucl Med Biol, 2013, 40(2)..206-213.
  • 9Agarwal A, Yadav AK, Kumar A, et al. Transarterial chemo embolization in unresectable hepatocellular carcinoma-assessing the factors affecting the survival= An audit from a tertiary care center in northern India [J~. Indian ] Gastroenterol, 2015, 34 (2) :117-126.
  • 10Meniconi RL, Komatsu S, Perdigao F, et al. Recurrent hepato- cellular carcinoma: a Western strategy that emphasizes the im- pact oI pathologic profile of the first resection [J~. Surgery, 2015, 157(3) :454-462.

引证文献1

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部